DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lomitapide
Lomitapide
Homozygous Familial Hypercholesterolemia - Juxtapid® (Lomitapide Capsules)
Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
Annexes of the Annual Report 2011
Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log
Bempedoic Acid
Juxtapid (Lomitapide)
Lomitapide for Treating Homozygous Familial Hypercholesterolaemia (Adults)
Juxtapid® (Lomitapide) P&T Approval Date 10/2015, 9/2016, 9/2017, 9/2018, 9/2019, 9/2020 Effective Date 12/1/2020; Oxford: N/A
Lojuxta, INN-Lomitapide
Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs
Study Protocol 1002-046 Amendment 1, 10 April 2017
Lipotropics, Other
Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
Juxtapid (Lomitapide)
Lojuxta, INN-Lomitapide
WO 2016/066256 Al 6 May 2016 (06.05.2016) W P O P C T
And Bempedoic Acid/Ezetimibe (Nexlizet™) New Drug Update
Juxtapid) Reference Number: CP.PHAR.283 Effective Date: 10.01.16 Last Review Date: 02.20 Revision Log Line of Business: Commercial, Medicaid
Top View
Severe Hypertriglyceridemia with Pancreatitisthirteen Years
Lomitapide (Juxtapid) Reference Number: PA.CP.PHAR.283 Effective Date: 01/18 Last Review Date: 10/17 Revision Log Line of Business: Medicaid
Juxtapid (Lomitapide) MCP-155
Study Protocol 1002-048 Amendment 2, 10 February 2017
211616Orig1s000
Juxtapid® (Lomitapide) Capsules Annual Review Date: 05/20/2021
WO 2015/167760 Al 5 November 2015 (05.11.2015) P O P C T
Bile Acid Sequestrants • Niacin • Fibrates • Mipomersen • Lomitapide • LDL Apheresis Evidence for Treating All FH Patients
Bempedoic Acid and Inclisiran for Patients with Heterozygous Familial Hypercholesterolemia and for Secondary Prevention of ASCVD: Effectiveness and Value
2020 Annual Report Will Be Remembered As the Year Everything Changed
Lomitapide (Juxtapid®)
JUXTAPID (Lomitapide)
ATC 2016.Xlsx
Treating Homozygous Familial Hypercholesterolemia in a Real-World Setting: Experiences with Lomitapide
Lomitapide (Juxtapid) Reference Number: ERX.SPMN.185 Effective Date: 01/2017 Revision Log Last Review Date
JUXTAPID (Lomitapide)
Trends in Lipid-Modifying Agent Use in 83 Countries
Juxtapid Lomitapide MCP
Study Protocol and Results
Cholesterol Lowering Agents
Effects (Critical Role) of Nitrite and Nitrate Determinants in Saliva And
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Effects of Mipomersen in Combination with Lomitapide in Homozygous Familial Hypercholesterolemia
Lomitapide (Juxtapid) Reference Number: PA.CP.PHAR.283 Effective Date: 01/18 Last Review Date: 01/19 Revision Log
Antihyperlipidemics – Apolipoprotein B Synthesis Inhibitors: Lomitapide Mesylate Medical Policy No
Lomitapide: a Review of Its Clinical Use, Efficacy, and Tolerability
Mipomersen and Lomitapide Background
Publication Agenda CHMP 07-10 December 2020
ATC Code Title
Lomitapide Mesylate (Juxtapid